Armgo Pharma
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
777 Old Saw Mill River Rd, Tarrytown, Ne...Phone Number
(914) 425-0000Website
www.armgo.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Armgo Pharma
Armgo Pharma, Inc. manufactures pharmaceutical products. Armgo Pharma was founded in 2004 and is based in New York, the United States.Explore more
Armgo Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Armgo Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Armgo Pharma launches new products
Congratulate Masked Content for being promoted to Masked Content at Armgo Pharma
Check out if Armgo Pharma is spiking on competitors!
Click to see if Armgo Pharma had a recent Job posting/layoffs
Check if Armgo Pharma has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Armgo Pharma has new funding data
Earning: See what the market has to say on Armgo Pharma recently announced quarterly report
Armgo Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Armgo Pharma as Masked Content
Find 2 more new buyers
Compare Similar Companies to Armgo Pharma
Compare insights from companies similar to Armgo Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Armgo Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Armgo Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Armgo Pharma.
Armgo Pharma financials insights
Gather financial insights about Armgo Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$35M
Armgo Pharma Tech Stack
A closer look at the technologies used by Armgo Pharma
See more technologies
Most Recent Scoops
New Hire
Executive Move
Yael Webb has joined the organization as Chief Operating Officer & General Counsel.
Executive Moves, New Hire
Funding
Pain Point
A mid-level source has indicated that the organization is experiencing challenges relating to security & compliance framework. Yael Webb serves as Senior VP, Intellectual Property (Clinical & Regulatory).
Pain Point, Information Security, Compliance, Legal Affairs, Security
Project
Enterprise Software, Legal Affairs, Records Management
Armgo Pharma News & Media
ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210 for the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia
ARDSLEY, N.Y.--(BUSINESS WIRE)--ARMGO Pharma, Inc. (ARMGO), a clinical stage biopharmaceutical company advancing a novel class of small molecule drugs known as Rycals®, announced today the enrollment of the first patient in a Phase 2 proof of concept clinical trial using its Rycal ARM210 (also known as S48168), for the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT). The trial, performed at the Amsterdam University Medical Center (Amsterdam UMC), Netherlands and the MaArmgo Pharma Raises $35M in Funding
Armgo Pharma, an Ardsley, New York-based novel small molecule therapeutics company developing treatments for cardiac, musculoskeletal, and neurological disorders, closed a $35m financing round. The round was led by Forbion with participation from Pontifax and Kurma Partners. In conjunction with the funding, Dr. Geert-Jan Mulder and Dr. Dmitrij Hristodorov from Forbion, Dr. Iyona Rajkomar from […] The post Armgo Pharma Raises $35M in Funding appeared first on FinSMEs.ARMGO® Pharma Inc. Announces Clinical Trial of ARM210/S48168 for the Treatment of Ryanodine Receptor Type 1 Related Myopathies
ARDSLEY, N.Y., Dec. 17, 2019 /PRNewswire/ -- ARMGO Pharma, Inc., a clinical stage biopharmaceutical company advancing a novel class of small molecule drugs known as Rycals®, announced today the start of a clinical trial using its Rycal ARM210 (also known as S48168), for the treatment for...ARMGO Pharma Receives FDA Orphan Drug Designation for ARM210/S48168 for the Treatment of Ryanodine Receptor Type 1 Related Myopathies
ARDSLEY, N.Y., Sept. 5, 2018 /PRNewswire/ -- ARMGO Pharma, Inc., a clinical stage biopharmaceutical company advancing a novel class of small molecule drugs known as Rycals®, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ARM210...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Armgo Pharma
Sign Up For FreeTo access detailed company insights
Armgo Pharma, Inc. manufactures pharmaceutical products. Armgo Pharma was founded in 2004 and is based in New York, the United States.... Read More
